Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function

Hypertension

Volumn 41, Issue 3 II, 2003, Pages 768-774

  Kuo, Jay J ^a   Silva, Alexandre A ^a   Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Heart rate; Hypertension, experimental; Hypertension, receptors, melanocortin; Insulin; Obesity

Indexed keywords

MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CATHETERIZATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INFUSION; FEEDING; FOOD INTAKE; HEART RATE; HYPERTENSION; HYPOPHAGIA; HYPOTHALAMUS; KIDNEY FUNCTION; LATERAL BRAIN VENTRICLE; LONG TERM EXPOSURE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ALPHA-MSH; ANIMALS; BLOOD PRESSURE; EATING; HEART RATE; HORMONES; HYPOTHALAMUS; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN; SODIUM; TIME FACTORS; URINE;

EID: 0037338712     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000048194.97428.1A     Document Type: Conference Paper

References (24)

1. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of the melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 1997;385:165-168.
2. Hagen MM, Rushing PA, Schwartz MA, Yagaloff KA, Burn P, Woods SC, Seeley RJ. Role of the CNS melanocortin system in the response to overfeeding. J Neurosci. 1999;19:2362-2367.
3. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131-141.
4. Sina M, Hinney A, Ziegler A, Neupert T, Mayer H, Siegfried W, Blum WF, Remschmidt H, Hebebrand J. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Ant J Hum Genet. 1999;65:1501-1507.
5. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 2000;106:253-262.
6. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett. 1998;249:107-110.
7. Haynes WG, Morgon DA, Djalali A, Sivitz WI, Mark AL. Interaction between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33:542-547.
8. Dunbar JC, Lu H. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull. 1999;50:215-221.
9. Ramaekers D, Beckers F, Demeulemeeter H, Bert C, Denef C, Aubert AE. Effects of melanocortins on cardiovascular regulation in rats. Clin Exp Pharmacol Physiol. 2002;29:549-558.
10. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. London: Academic Press; 1998.
11. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:409-414.
12. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension. 2002;39:496-501.
13. Kuo JJ, Jones OB, Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension. 2001;37:670-676.
14. Murphy B, Nunes CN, Ronan JJ, Hanaway M, Fairhurst AM, Mellin TN. Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J Appl Physiol. 2000;89:273-282.
15. Jonsson L, Skarphedinsson JO, Skuladottir GV, Watanobe H, Schioth HB. Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J Endocrinol. 2002;173:517-523.
16. Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes. 2002;51:1337-1345.
17. Widdowson PS, Upton R, Henderson L, Buckingham R, Wilson S, Williams G. Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat. Brain Res. 1997;774:1-10.
18. Thornton JE, Cheung CC, Clifton DK, Steiner RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Nature. 1994;372:425-432.
19. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14:103S-115S.
20. Adage T, Scheurink AJW, de Boer SF, de Vries K, Konsman JP, Kuipers F, Adan RAH, Baskin DG, Schwartz MW, van Dijk G. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci. 2001;21:3639-3645.
21. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD. The central melanocortin system can directly regulate serum insulin levels. Endocrinology. 2000;141:3072-3079.
22. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest. 2001;108:1079-1085.
23. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens. 1999;17:1949-1953.
24. Correia MLG, Morgan DA, Sivitz WI, Mark AL, Haynes WG. Hemodynamic consequences of neuropeptide Y-induced obesity. Am J Hypertens. 2002;15:137-142.